Antipyrine

규격

60-80-0CAS 번호

200-486-6EC 번호

1,5-dimethyl-2-phenylpyrazol-3-oneIUPAC 명칭

C11H12N2O화학식

188.23 g/mol분자량

antipyrine; Phenazone; 60-80-0; Analgesine; Antipyrin; Fenazone; Antipyrinum; Phenazonum; 2,3-Dimethyl-1-phenyl-5-pyrazolone; Fenazona; 3H-Pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-2-phenyl-; 2,3-Dimethyl-1-phenyl-3-pyrazolin-5-one; 1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one; 1,5-Dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one; 1,5-dimethyl-2-phenylpyrazol-3-one; DTXSID6021117; CHEBI:31225; 1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one; T3CHA1B51H; DTXCID401117; RefChem:54230; N02BB01; S02DA03; 200-486-6; Anodynin; Anodynine; Azophen; Antipirin; Phenozone; Phenylone; Dimethyloxychinizin; Apirelina; Azophene; Methozin; Parodyne; Pyrazophyl; Sedatine; Dimethyloxyquinazine; Oxydimethylquinazine; Azophenum; Phenylon; 3-Antipyrine; Fenazon [Czech]; Oxydimethylquinizine; Fenazona [INN-Spanish]; Phenazone (pharmaceutical); Fenazon; 1-Phenyl-2,3-dimethyl-5-pyrazolone; 1-Phenyl-2,3-dimethylpyrazole-5-one; NSC 7945; Phenazone;Phenazon; MFCD00003146; Phenazone [INN]; 1,5-dimethyl-2-phenyl-1,2-dihydropyrazol-3-one; 1,5-dimethyl-2-phenyl-pyrazol-3-one; Phenazone (INN); NSC-7945; s3173; CAS-60-80-0; NCGC00016274-04; Antipyrine [JAN]; Phenazonum [INN-Latin]; SMR000238140; CCRIS 1369; Antipyrine [USP:JAN]; SR-05000001566; EINECS 200-486-6; pyrazole, 2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-; UNII-T3CHA1B51H; Antipyrien; AI3-15293; Phenazone CRS; .beta.-Antipyrine; Prestwick_26; component of Auralgan; Antipyrine (Standard); Spectrum_000058; ANTIPYRINE [MI]; Prestwick0_000029; Prestwick1_000029; Prestwick2_000029; Prestwick3_000029; Spectrum2_000088; Spectrum3_000305; Spectrum4_000152; Spectrum5_000842; ANTIPYRINE [VANDF]; ANTIPYRINUM [HPUS]; Antipyrine (JP17/USP); Epitope ID:124927; PHENAZONE [MART.]; EC 200-486-6; PHENAZONE [WHO-DD]; 1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one; ANTIPYRINE [USP-RS]; Auralgan component antipyrine; SCHEMBL20452; BSPBio_000097; BSPBio_001870; KBioGR_000624; KBioSS_000438; MLS001331753; MLS001332401; MLS001332402; MLS002154179; DivK1c_000484; SPECTRUM1500128; SPBio_000016; SPBio_002018; Antipyrine, analytical standard; BPBio1_000107; CHEMBL277474; orb1310338; orb3139301; SCHEMBL3065572; PHENAZONE [EP IMPURITY]; 2-Trideuteromethyl-3-methyl-1-phenyl-3-pyrazolin-5-one; PHENAZONE [EP MONOGRAPH]; HMS501I06; HY-B0171R; KBio1_000484; KBio2_000438; KBio2_003006; KBio2_005574; KBio3_001370; ANTIPYRINE [USP IMPURITY]; MSK7125; NSC7945; Antipyrine, >=99.0% (RT); NINDS_000484; ANTIPYRINE [USP MONOGRAPH]; HMS1568E19; HMS1920E09; HMS2091K09; HMS2095E19; HMS2272G04; HMS3652C09; HMS3712E19; HMS3885C11; HMS5081O22; Pharmakon1600-01500128; WLN: T5NNVJ A1 BR& E1; HY-B0171; Tox21_110342; Tox21_201600; Tox21_303026; Antipyrine, Sigma Reference Standard; BDBM50103600; CCG-38904; EBC-03511; NSC755874; SBB017226; STK328171; 1,5-Dimethyl-2-phenyl-3-pyrazolone; AKOS000588788; MSK7125-1000A; Tox21_110342_1; CS-2044; DB01435; FD75059; NSC-755874; IDI1_000484; Phenazone 10 microg/mL in Acetonitrile; Antipyrine, analytical reference material; Antipyrine, tested according to Ph.Eur.; Antipyrine; Propyphenazone EP Impurity A; NCGC00016274-01; NCGC00016274-02; NCGC00016274-03; NCGC00016274-05; NCGC00016274-06; NCGC00016274-07; NCGC00016274-09; NCGC00016274-10; NCGC00094591-01; NCGC00094591-02; NCGC00094591-03; NCGC00178937-01; NCGC00178937-02; NCGC00256527-01; NCGC00259149-01; AS-13248; ST009485; SBI-0051287.P003; Antipyrine, Vetec(TM) reagent grade, 98%; D1876; NS00000287; SW196343-3; T0734; EN300-17057; BIM-0051287.0001; D01776; H11233; PROPYPHENAZONE IMPURITY A [EP IMPURITY]; Antipyrine Solution in Acetonitrile, 1000ug/mL; AF-960/00437050; F358184; P286177; Q415578; SR-05000001566-1; SR-05000001566-3; BRD-K46937689-001-05-1; BRD-K46937689-001-08-5; BRD-K46937689-001-14-3; BRD-K46937689-001-15-0; Z56869297; F2173-0728; 1,5-Dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one #; Phenazone, European Pharmacopoeia (EP) Reference Standard; Antipyrine, United States Pharmacopeia (USP) Reference Standard동의어